DEA Proposes Rule to Remove Exemption for Certain Pseudoephedrine Products Under FD&C Act

Summary

The Drug Enforcement Administration (DEA) is proposing a rule to remove exemptions for certain over-the-counter pseudoephedrine products from the Controlled Substances Act, due to their potential use in clandestine manufacturing of controlled substances, and to reduce the threshold for pseudoephedrine to 24.0 grams base, allowing for a 120-day supply without regulatory requirements.